Revenue
-
Net Income
-$14.5M
▲ 22.2% YoY
EPS
$-6.83
▲ 59.7% YoY
Cash
$8.8M
▲ 49.5% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Eylward Susan General Counsel and Corp Sec | Sell | Aug 31, 2026 | 2.5K | $1.56 | $4K | Form 4 ↗ |
Tardugno Michael H Executive Chairman of Board | Grant | Aug 28, 2026 | 7.4K | $1.60 | $12K | Form 4 ↗ |
Lindborg Stacy President and CEO | Grant | Aug 28, 2026 | 6.8K | $1.60 | $11K | Form 4 ↗ |
Faller Douglas Vincent Chief Medical Officer | Grant | Aug 28, 2026 | 3.6K | $1.60 | $6K | Form 4 ↗ |
Eylward Susan General Counsel and Corp Sec | Grant | Aug 28, 2026 | 2.5K | $1.60 | $4K | Form 4 ↗ |
Eylward Susan General Counsel and Corp Sec | Sell | Aug 17, 2026 | 2.4K | $1.63 | $4K | Form 4 ↗ |
Lindborg Stacy President and CEO | Grant | Aug 14, 2026 | 6.6K | $1.65 | $11K | Form 4 ↗ |
Faller Douglas Vincent Chief Medical Officer | Grant | Aug 14, 2026 | 3.5K | $1.65 | $6K | Form 4 ↗ |
Tardugno Michael H Executive Chairman of Board | Grant | Aug 14, 2026 | 7.1K | $1.65 | $12K | Form 4 ↗ |
Eylward Susan General Counsel and Corp Sec | Grant | Aug 14, 2026 | 2.4K | $1.65 | $4K | Form 4 ↗ |
Pellizzari Christine A Director | Grant | Jul 31, 2026 | 6.9K | $1.59 | $11K | Form 4 ↗ |
Dentzer James E Director | Grant | Jul 31, 2026 | 6.9K | $1.59 | $11K | Form 4 ↗ |
Fritz Frederick J. Director | Grant | Jul 31, 2026 | 6.9K | $1.59 | $11K | Form 4 ↗ |
Braun Donald P Director | Grant | Jul 31, 2026 | 6.2K | $1.59 | $10K | Form 4 ↗ |